Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

Recombinant Human Glypican 3, CF

Name Recombinant Human Glypican 3, CF
Supplier R&D Systems
Catalog 2119-GP-050/CF
Category Protein
Nature Recombinant
Source Mouse myeloma cell line, NS0-derived, Met1-His559 with a C-terminal 6-His tag
Purity >97%, by SDS-PAGE with silver staining.
SwissProt/Accession P51654.1
Gene GPC3
Supplier Page Shop

Product References

Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular - Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular

Sawada Y, Yoshikawa T, Nobuoka D, Shirakawa H, Kuronuma T, Motomura Y, Mizuno S, Ishii H, Nakachi K, Konishi M, Nakagohri T, Takahashi S, Gotohda N, Takayama T, Yamao K, Uesaka K, Furuse J, Kinoshita T, Nakatsura T. Clin Cancer Res. 2012 Jul 1;18(13):3686-96.

Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently - Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently

Motomura Y, Senju S, Nakatsura T, Matsuyoshi H, Hirata S, Monji M, Komori H, Fukuma D, Baba H, Nishimura Y. Cancer Res. 2006 Feb 15;66(4):2414-22.

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for - Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for

Komori H, Nakatsura T, Senju S, Yoshitake Y, Motomura Y, Ikuta Y, Fukuma D, Yokomine K, Harao M, Beppu T, Matsui M, Torigoe T, Sato N, Baba H, Nishimura Y. Clin Cancer Res. 2006 May 1;12(9):2689-97.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved